LineLabelWBD-PValueSourceMessage
1Dimensions period from 2001-01-01 to 2001-12-31 for SAMP Scenario-5
2U-Monetary
3company:By Product (Placeholder)//products:All Products
4ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF32,465,000bothOK
5ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF11,561,500inst 
6ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF10,879,375inst 
7ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF4,851,500inst 
8ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF5,172,625inst 
 
9company:By Product (Placeholder)//products:Consumer Health Segment
10ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF7,421,100bothOK
11ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF2,569,580inst 
12ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF2,462,040inst 
13ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF1,024,600inst 
14ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,364,880inst 
 
15company:By Product (Placeholder)//products:Generics Segment
16ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF4,158,000bothOK
17ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF1,378,300inst 
18ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF1,358,625inst 
19ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF503,300inst 
20ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF917,775inst 
 
21company:By Product (Placeholder)//products:Other Segments
22ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF8,378,650bothOK
23ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF3,038,070inst 
24ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF2,826,185inst 
25ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF1,314,600inst 
26ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,199,795inst 
 
27company:By Product (Placeholder)//products:Pharmaceuticals Segment
28ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF12,507,250bothOK
29ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF4,575,550inst 
30ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF4,232,525inst 
31ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF2,009,000inst 
32ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,690,175inst 
 
33company:By Region (Placeholder)//regions:All Regions
34ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF32,465,000bothOK
35ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF12,507,250inst 
36ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF4,158,000inst 
37ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF7,421,100inst 
38ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF8,378,650inst 
 
39company:By Region (Placeholder)//regions:Asia Region
40ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF4,851,500bothOK
41ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF2,009,000inst 
42ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF503,300inst 
43ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF1,024,600inst 
44ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,314,600inst 
 
45company:By Region (Placeholder)//regions:Europe Region
46ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF10,879,375bothOK
47ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF4,232,525inst 
48ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,358,625inst 
49ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF2,462,040inst 
50ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF2,826,185inst 
 
51company:By Region (Placeholder)//regions:Other Regions
52ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF5,172,625bothOK
53ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF1,690,175inst 
54ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF917,775inst 
55ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF1,364,880inst 
56ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,199,795inst 
 
57company:By Region (Placeholder)//regions:US and Canada Region
58ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF11,561,500bothOK
59ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF4,575,550inst 
60ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,378,300inst 
61ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF2,569,580inst 
62ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF3,038,070inst 
 
63Dimensions period from 2002-01-01 to 2002-12-31 for SAMP Scenario-5
64U-Monetary
65company:By Product (Placeholder)//products:All Products
66ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF35,805,000bothOK
67ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF13,485,500inst 
68ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF11,452,875inst 
69ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF5,766,000inst 
70ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF5,100,625inst 
 
71company:By Product (Placeholder)//products:Consumer Health Segment
72ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF8,269,700bothOK
73ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF3,073,660inst 
74ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF2,592,310inst 
75ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF1,263,340inst 
76ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,340,390inst 
 
77company:By Product (Placeholder)//products:Generics Segment
78ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF4,567,000bothOK
79ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF1,659,500inst 
80ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF1,382,675inst 
81ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF634,400inst 
82ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF890,425inst 
 
83company:By Product (Placeholder)//products:Other Segments
84ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF8,522,550bothOK
85ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF3,224,990inst 
86ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF2,745,540inst 
87ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF1,397,610inst 
88ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,154,410inst 
 
89company:By Product (Placeholder)//products:Pharmaceuticals Segment
90ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF14,445,750bothOK
91ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF5,527,350inst 
92ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF4,732,350inst 
93ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF2,470,650inst 
94ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,715,400inst 
 
95company:By Region (Placeholder)//regions:All Regions
96ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF35,805,000bothOK
97ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF14,445,750inst 
98ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF4,567,000inst 
99ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF8,269,700inst 
100ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF8,522,550inst 
 
101company:By Region (Placeholder)//regions:Asia Region
102ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF5,766,000bothOK
103ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF2,470,650inst 
104ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF634,400inst 
105ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF1,263,340inst 
106ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,397,610inst 
 
107company:By Region (Placeholder)//regions:Europe Region
108ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF11,452,875bothOK
109ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF4,732,350inst 
110ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,382,675inst 
111ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF2,592,310inst 
112ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF2,745,540inst 
 
113company:By Region (Placeholder)//regions:Other Regions
114ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF5,100,625bothOK
115ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF1,715,400inst 
116ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF890,425inst 
117ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF1,340,390inst 
118ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,154,410inst 
 
119company:By Region (Placeholder)//regions:US and Canada Region
120ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF13,485,500bothOK
121ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF5,527,350inst 
122ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,659,500inst 
123ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF3,073,660inst 
124ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF3,224,990inst 
 
125Dimensions period from 2003-01-01 to 2003-12-31 for SAMP Scenario-5
126U-Monetary
127company:By Product (Placeholder)//products:All Products
128ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF32,038,000bothOK
129ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF11,514,600inst 
130ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF11,557,150inst 
131ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF6,023,300inst 
132ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF2,942,950inst 
 
133company:By Product (Placeholder)//products:Consumer Health Segment
134ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF7,822,820bothOK
135ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF2,764,960inst 
136ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF2,834,265inst 
137ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF1,456,960inst 
138ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF766,635inst 
 
139company:By Product (Placeholder)//products:Generics Segment
140ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF4,420,300bothOK
141ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF1,508,000inst 
142ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF1,615,875inst 
143ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF807,200inst 
144ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF489,225inst 
 
145company:By Product (Placeholder)//products:Other Segments
146ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF4,898,680bothOK
147ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF1,673,340inst 
148ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF1,790,185inst 
149ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF895,190inst 
150ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF539,965inst 
 
151company:By Product (Placeholder)//products:Pharmaceuticals Segment
152ci:Sales[..., company:By Region (Placeholder)//regions:All Regions] CINF14,896,200bothOK
153ci:Sales[..., company:By Region (Placeholder)//regions:US and Canada Region]1CINF5,568,300inst 
154ci:Sales[..., company:By Region (Placeholder)//regions:Europe Region]1CINF5,316,825inst 
155ci:Sales[..., company:By Region (Placeholder)//regions:Asia Region]1CINF2,863,950inst 
156ci:Sales[..., company:By Region (Placeholder)//regions:Other Regions]1CINF1,147,125inst 
 
157company:By Region (Placeholder)//regions:All Regions
158ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF32,038,000bothOK
159ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF14,896,200inst 
160ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF4,420,300inst 
161ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF7,822,820inst 
162ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF4,898,680inst 
 
163company:By Region (Placeholder)//regions:Asia Region
164ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF6,023,300bothOK
165ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF2,863,950inst 
166ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF807,200inst 
167ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF1,456,960inst 
168ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF895,190inst 
 
169company:By Region (Placeholder)//regions:Europe Region
170ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF11,557,150bothOK
171ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF5,316,825inst 
172ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,615,875inst 
173ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF2,834,265inst 
174ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,790,185inst 
 
175company:By Region (Placeholder)//regions:Other Regions
176ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF2,942,950bothOK
177ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF1,147,125inst 
178ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF489,225inst 
179ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF766,635inst 
180ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF539,965inst 
 
181company:By Region (Placeholder)//regions:US and Canada Region
182ci:Sales[..., company:By Product (Placeholder)//products:All Products] CINF11,514,600bothOK
183ci:Sales[..., company:By Product (Placeholder)//products:Pharmaceuticals Segment]1CINF5,568,300inst 
184ci:Sales[..., company:By Product (Placeholder)//products:Generics Segment]1CINF1,508,000inst 
185ci:Sales[..., company:By Product (Placeholder)//products:Consumer Health Segment]1CINF2,764,960inst 
186ci:Sales[..., company:By Product (Placeholder)//products:Other Segments]1CINF1,673,340inst 


Contexts
IDD-2003-Asia-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-Europe-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-US-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-OtherRegions-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-All-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-Asia-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-Europe-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-US-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-OtherRegions-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2002-All-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-Asia-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-Europe-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-US-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-OtherRegions-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2001-All-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:All Products
 
IDD-2003-ConHealth-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-ConHealth-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-ConHealth-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-ConHealth-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-ConHealth-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2003-Gen-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-Gen-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-Gen-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-Gen-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-Gen-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2003-OtherSeg-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-OtherSeg-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-OtherSeg-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-OtherSeg-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-OtherSeg-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2003-Pharm-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2003-Pharm-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2003-Pharm-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2003-Pharm-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2003-Pharm-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2003-01-01 to 2003-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-ConHealth-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-ConHealth-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-ConHealth-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-ConHealth-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-ConHealth-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2002-Gen-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-Gen-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-Gen-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-Gen-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-Gen-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2002-OtherSeg-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-OtherSeg-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-OtherSeg-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-OtherSeg-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-OtherSeg-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2002-Pharm-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-Pharm-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-Pharm-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-Pharm-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2002-Pharm-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2002-01-01 to 2002-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-ConHealth-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-ConHealth-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-ConHealth-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-ConHealth-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-ConHealth-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Consumer Health Segment
 
IDD-2001-Gen-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-Gen-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-Gen-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-Gen-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-Gen-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Generics Segment
 
IDD-2001-OtherSeg-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-OtherSeg-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-OtherSeg-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-OtherSeg-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-OtherSeg-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Other Segments
 
IDD-2001-Pharm-Asia
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Asia Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-Pharm-Europe
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Europe Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-Pharm-OtherRegions
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:Other Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-Pharm-US
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:US and Canada Region
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment
 
IDD-2001-Pharm-All
Entity IDSAMP
Schemehttp://www.SampleCompany.com
Periodfrom 2001-01-01 to 2001-12-31
Scenariocompany:By Region (Placeholder)//regions:All Regions
Scenariocompany:By Product (Placeholder)//products:Pharmaceuticals Segment


Extended Links
ID
RoleDefault Link [http://www.xbrl.org/2003/role/link]
ID
RoleHypercube [http://www.SampleCompany.com/Hypercube]
ID
RolePrimaryConcepts [http://www.SampleCompany.com/PrimaryConcepts]


Units
IDU-Monetary
Measure<measure>iso4217:EUR</measure>


Performance Statistics
(seconds)
DTS grammars cached0
XML Validation0.0901296
Numeric context period checks0.0100144
Build calculation tree graph0
Evaluate formula dependency0
Evaluate required and essence-aliased facts0.1301872
Calculation tree roll-ups pass 10
Independent formula execution 0
Begin dimension rollup validation0
... Sales roll-ups pass 11.0615264
Update displayed instance0
Finish0

Product version: 6.403.2221.19361 (2006-01-30 11:45)

Software and look and feel © 2002-2006
Universal Business Matrix, inc (UBmatrix)
803 Kirkland Avenue, Suite 200
Kirkland, Washington, USA 98033-6318